Ratio Therapeutics

Radiopharmaceutical
#Collaboration #Radiopharmaceuticals #Ratio Therapeutics #RayzeBio

Ratio Therapeutics and RayzeBio advance novel radiopharmaceuticals

Ratio Therapeutics and RayzeBio have entered into a research collaboration and license agreement to advance a novel radiopharmaceutical programme focused on two undisclosed targets.  Under the terms of the agreement, Ratio will receive an upfront payment and is eligible to receive development, regulatory and commercial milestone payments, as well as… Read More

#Business & Investment #News